We are live on ! Find out more
AAA

Affinity Asset Advisors Portfolio holdings

AUM $1.94B
1-Year Est. Return 374.45%
This Fund
S&P 500
This Quarter Est. Return
+15.33%
1 Year Est. Return
+374.45%
3 Year Est. Return
+1,279.72%
5 Year Est. Return
+2,528.28%
10 Year Est. Return
–
AUM
$294M
AUM Growth
+$106M
Cap. Flow
+$106M
Cap. Flow %
35.98%
Top 10 Hldgs %
58.58%
Holding
91
New
29
Increased
26
Reduced
8
Closed
19

Top Buys

Rank Stock Value
1
BBIO icon
BridgeBio Pharma
BBIO
+$27.6M
2
ARYD
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
+$7.56M
3
TVTX icon
Travere Therapeutics
TVTX
+$6.08M
4
MORF
Morphic Holding, Inc. Common Stock
MORF
+$5.85M
5
NAUT icon
Nautilus Biotechnolgy
NAUT
+$5.39M

Top Sells

Rank Stock Value
1
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$29.6M
2
CRIS icon
Curis
CRIS
+$4.71M
3
STRO icon
Sutro Biopharma
STRO
+$2.85M
4
ATNX
Athenex, Inc. Common Stock
ATNX
+$2.21M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.2M

Sector Composition

Rank Sector Weight
1 Healthcare 63.48%
2 Financials 2.49%
3 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LYRA
76
DELISTED
LYRA THERAPEUTICS INC
LYRA
– –
-1,000
Closed -$570K
MDGL icon
77
Madrigal Pharmaceuticals
MDGL
$12.4B
– –
-5,000
Closed -$556K
MGTX icon
78
MeiraGTx Holdings
MGTX
$1.13B
– –
-100,000
Closed -$1.51M
OM icon
79
Outset Medical
OM
$75.8M
– –
-667
Closed -$568K
SKIN icon
80
SkinHealth Systems
SKIN
$106M
– –
-100,000
Closed -$1.13M
SLDB icon
81
CALL
Solid Biosciences
SLDB
$849M
– –
-16,667
Closed -$1.9M
VRTX icon
82
Vertex Pharmaceuticals
VRTX
$122B
– –
-10,000
Closed -$2.2M
VXRT
83
PUT
DELISTED
Vaxart
VXRT
– –
-25,000
Closed -$143K
MRTX
84
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-10,000
Closed -$2.2M
SIOX
85
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
– –
-250,000
Closed -$695K
ATNX
86
DELISTED
Athenex, Inc. Common Stock
ATNX
– –
-10,000
Closed -$2.21M
RCOR
87
DELISTED
Renovacor, Inc.
RCOR
– –
-75,000
Closed -$794K
DRNA
88
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-40,000
Closed -$881K
PAND
89
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
– –
-80,000
Closed -$1.19M
EIDX
90
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
– –
-225,000
Closed -$29.6M
1 2 3
4

Similar funds

FM
Foster & Motley Cincinnati, Ohio $1.94B AUM 21.65% 1-Year Est. Return
1SB
1ST Source Bank South Bend, Indiana $1.94B AUM 20.3% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return
OCM
Osterweis Capital Management San Francisco, California $1.94B AUM 20.77% 1-Year Est. Return
MWA
Midland Wealth Advisors Effingham, Illinois $1.94B AUM 14.31% 1-Year Est. Return
AF
Advisornet Financial Minnetonka, Minnesota $1.93B AUM 18.43% 1-Year Est. Return
NFG
Nations Financial Group Cedar Rapids, Iowa $1.94B AUM 25.76% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM

Affinity Asset Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Affinity Asset Advisors held 91 positions worth $294M, up 56% from $189M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Affinity Asset Advisors deployed $106M of net new capital in Q1 2021, opening 29 new positions and adding to 26 existing holdings. Its largest new stake was ARYA Sciences Acquisition Corp IV Class A Odinary Shares: 700,000 shares worth $7.33M.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, down from 81% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was Curis, an estimated $4.71M trimmed.

  • Affinity Asset Advisors's largest Q1 2021 buy was ARYA Sciences Acquisition Corp IV Class A Odinary Shares: 700,000 shares worth $7.33M.
  • Affinity Asset Advisors added most to BridgeBio Pharma in Q1 2021, an estimated $27.6M increase.
  • Affinity Asset Advisors's biggest Q1 2021 reduction was Curis, cutting an estimated $4.71M.
  • Affinity Asset Advisors fully exited Eidos Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $29.6M.
  • Affinity Asset Advisors's ten largest holdings make up 59% of its $294M portfolio in Q1 2021.
  • Affinity Asset Advisors opened 29 new positions and closed 19 in Q1 2021.
  • Affinity Asset Advisors's portfolio value rose 56% quarter-over-quarter to $294M.

Based on Affinity Asset Advisors's 13F filing for Q1 2021, filed 14 May 2021.